ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ATHA Athira Pharma Inc

2.64
0.08 (3.12%)
29 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Athira Pharma Inc ATHA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.08 3.12% 2.64 11:00:00
Open Price Low Price High Price Close Price Previous Close
2.59 2.55 2.825 2.74 2.56
more quote information »

Recent News

Date Time Source Heading
08/3/202423:00GLOBEAthira Pharma Presents Clinical and Preclinical Data..
23/2/202408:34EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/2/202408:10EDGAR2Form 8-K - Current report
23/2/202408:05GLOBEAthira Pharma Reports Full Year 2023 Financial Results and..
17/2/202409:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202408:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202408:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202408:40EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
09/2/202408:02GLOBEAthira Pharma Announces Publication in Frontiers in..
09/1/202408:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202408:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202408:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202408:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202423:11EDGAR2Form 8-K - Current report
08/1/202423:00GLOBEAthira Pharma Provides 2024 Clinical Pipeline Outlook and..
03/1/202423:00GLOBEAthira Pharma Completes Enrollment of Phase 2/3 LIFT-AD..
12/12/202323:00GLOBEAthira Pharma Announces Encouraging Results from SHAPE Phase..
29/11/202323:00GLOBEAthira Pharma to Participate in Sidoti December Small Cap..
28/11/202323:00GLOBEAthira Pharma Announces Upcoming Presentation at Motor..
16/11/202300:15GLOBEAthira Pharma Presents Preclinical Data Highlighting..
10/11/202308:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202308:10EDGAR2Form 8-K - Current report
10/11/202308:05GLOBEAthira Pharma Reports Third Quarter 2023 Financial Results..
08/11/202323:00GLOBEAthira Pharma to Participate in Jefferies London Healthcare..
06/10/202307:30GLOBEAthira Pharma Presents Preclinical Data Further Supporting..
28/9/202321:00GLOBEAthira Pharma to Participate in Upcoming October Conferences
19/9/202321:00GLOBEAthira Pharma to Participate in the 2023 Cantor Fitzgerald..
11/8/202306:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202306:10EDGAR2Form 8-K - Current report
11/8/202306:05GLOBEAthira Pharma Reports Second Quarter 2023 Financial Results..
17/7/202321:00GLOBEAthira Pharma Presents Phase 2 Clinical Data Correlating..
06/7/202321:00GLOBEAthira Pharma Announces Upcoming Presentations at the..
31/5/202321:00GLOBEAthira Pharma to Participate in Upcoming June Conferences
22/5/202321:00GLOBEAthira Pharma Appoints Andrew Gengos as Chief Financial..
12/5/202306:05GLOBEAthira Pharma Reports First Quarter 2023 Financial Results..
08/5/202321:00GLOBEAthira Pharma to Participate in Upcoming May Investor..
26/4/202306:01GLOBEAthira Pharma Presents New Clinical and Preclinical Data at..
11/4/202321:00GLOBEAthira Pharma Announces Upcoming Presentations at the..

Your Recent History

Delayed Upgrade Clock